MicroRNA 6509 (MIR6509)

MicroRNA 6509 (MIR6509) is a human microRNA gene encoding a small non-coding RNA that plays a role in the post-transcriptional regulation of gene expression. Like other microRNAs, the mature product of MIR6509 is processed from a stem-loop precursor, is incorporated into the RNA-induced silencing complex (RISC), and targets mRNAs through imperfect base pairing, generally leading to translational inhibition or destabilization of the target mRNA. Diseases associated with MIR6509 include immature cataract. However, there is no evidence that MIR6509 itself is a canonical drug target like a receptor, enzyme, or transporter; it does not conventionally interact with drugs, nor is it broadly recognized as a therapeutic target[1][2]. The locus and sequence are registered (e.g., HGNC: 50207), but there is minimal specific literature or data beyond its classification as a microRNA of still largely unknown specific biological or pharmacological significance[1]. Key issues: - MicroRNAs are not classic "targets" in the sense of drug receptors or enzymes. - There is scant functional or clinical data on MIR6509 compared to well-characterized microRNAs; most information about miRNAs pertains to the class as a whole, not specifically MIR6509[1][4]. Therefore, MIR6509 should be flagged as not a recognized druggable target and may have ambiguous or insufficient information in the context of therapeutic targeting[1][2].

Other names

hsa-mir-6509microRNA mir-6509MIR6509